Research is a major strength of our program and we recognize that scholarly activity is an important means for residents to advance their career goals.  Residents are provided with a protected research block in their first year, in addition to a further two blocks of electives in the second year that can also be used for research purposes. After meeting with both the Research Director and Program Director, residents will initiate a research project and will be expected to present at a local, national, or international research forum.  Regular teaching sessions in research methodology, epidemiology, and biostatics are provided,  and residents may also apply for admission to the RCPSC-accredited Clinician Investigator Program at Queen’s.

The Division of Hematology at Queen’s is a leading centre for hemostasis research. The Molecular Hemostasis Laboratory utilizes a variety of experimental approaches to understand the molecular basis of blood coagulation and develops strategies to translate this knowledge into clinical benefits.  Its Principal Investigators were winners of the National Hemophillia Foundation’s ‘Researchers of the Year Award of Excellence’ in 2011.

Additionally Kingston is the home of the NCIC Clinical Trials Group, Canada's premiere cooperative oncology group, which carries out clinical trials in cancer therapy, supportive care and prevention with internationally recognized clinical trialists based in Kingston.  There is much opportunity for involvement in research focused on hematologic malignancy.